. 2016 Sep 15;5(1):1568. doi: 10.1186/s40064-016-3249-3

Table 2.

Histological assessment of myocyte size, vessel density and myocardial fibrosis

Histological parameters	Group	Mean ± SD	p value
Myocyte size (baseline) (μm²)	Amiodarone	326.24 ± 58.30	0.197
Myocyte size (baseline) (μm²)	Control	264.60 ± 71.70	0.197
Vascular density (baseline) (vessels/0.1 mm²)	Amiodarone	150 ± 100	0.073
Vascular density (baseline) (vessels/0.1 mm²)	Control	340 ± 90	0.073
Myocardial fibrosis (baseline) (%/area)	Amiodarone	8.44 ± 7.21	0.839
Myocardial fibrosis (baseline) (%/area)	Control	9.48 ± 5.57	0.839
Myocyte size (3 months) (μm²)	Amiodarone	638.22 ± 259.70	0.874
Myocyte size (3 months) (μm²)	Control	607.31 ± 245.06	0.874
Vascular density (3 months) (vessels/0.1 mm²)	Amiodarone	150 ± 100	0.150
Vascular density (3 months) (vessels/0.1 mm²)	Control	310 ± 100	0.150
Myocardial fibrosis (3 months) (%/area)	Amiodarone	11.60 ± 2.98	0.474
Myocardial fibrosis (3 months) (%/area)	Control	16.43 ± 14.12	0.474